Clinical Trials
21 trialsNCT00526318 2015-07-16
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
National Cancer Institute (NCI)
Phase NA Unknown
NCT00030719 2014-06-24
Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00084695 2014-01-10
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00101309 2013-12-18
Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00769613 2013-12-18
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00036712 2013-09-20
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00281905 2013-09-20
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00349024 2013-09-20
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00416559 2013-09-20
Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003743 2013-09-17
Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00276731 2013-09-17
Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00287950 2013-09-17
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
National Cancer Institute (NCI)
Phase NA Unknown
NCT00392340 2013-09-17
Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003122 2013-08-26
Surgery in Treating Patients With Neuroblastoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00939965 2013-08-12
Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
National Cancer Institute (NCI)
Phase NA Unknown
NCT00024193 2013-08-07
Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00410631 2013-08-07
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00416676 2013-08-02
Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00417053 2013-08-02
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00072488 2010-06-08
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase NA Unknown
NCT00013806 2005-06-24
CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study
National Center for Research Resources (NCRR)
Phase 2 Unknown